| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/30/2003 | CA2417907A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 01/30/2003 | CA2417845A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
| 01/30/2003 | CA2395992A1 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and a sh3 domain comprising peptide |
| 01/29/2003 | WO2002010350A1 Method of proliferating natural killer cells |
| 01/29/2003 | EP1279739A1 Recombinant vectors derived from adeno-associated virus expressing TAM67 for gene therapy |
| 01/29/2003 | EP1279677A1 Gd3-mimetic peptides |
| 01/29/2003 | EP1279676A1 Porphyrin derivatives for photodynamic therapy |
| 01/29/2003 | EP1279406A1 Transporters and drug delivery system by using the same |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279039A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/29/2003 | EP1278893A2 Diagnosis of diseases associated with dna replication |
| 01/29/2003 | EP1278874A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278868A2 Novel mutated form of arginine deiminase |
| 01/29/2003 | EP1278859A2 Human protein kinases and protein kinase-like enzymes |
| 01/29/2003 | EP1278851A1 Humanised antibodies to the epidermal growth factor receptor |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278827A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/29/2003 | EP1278826A1 Novel proteins |
| 01/29/2003 | EP1278825A2 Methods of producing membrane vesicles |
| 01/29/2003 | EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |
| 01/29/2003 | EP1278763A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 01/29/2003 | EP1278759A1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 01/29/2003 | EP1278750A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 01/29/2003 | EP1278749A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/29/2003 | EP1278735A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 01/29/2003 | EP1278734A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 01/29/2003 | EP1278732A1 1-aroyl-piperidinyl benzamidines |
| 01/29/2003 | EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments |
| 01/29/2003 | EP1278547A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278542A2 Molecular antigen arrays and vaccines |
| 01/29/2003 | EP1278539A1 Omp protein associated with autologous and/or heterologous tumour cell lysate |
| 01/29/2003 | EP1278536A1 Depletion method of blood plasma ascorbate |
| 01/29/2003 | EP1278535A2 Uses of tgap7 for the modulation of leucocyte activation |
| 01/29/2003 | EP1278528A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 01/29/2003 | EP1278523A2 Combination of progesterone and mifepristone for cancer therapy |
| 01/29/2003 | EP1278521A2 Use of n-heterocyclic substituted salicylates for inhibition of cellular uptake of cystine |
| 01/29/2003 | EP1278519A2 Method for treating a patient with neoplasia by treatment with a topoisomerase i inhibitor |
| 01/29/2003 | EP1278518A2 A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 01/29/2003 | EP1278512A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 01/29/2003 | EP1278412A2 Polymer conjugates of ara-c and ara-c derivatives |
| 01/29/2003 | EP1064257B1 Anti-tumour agents |
| 01/29/2003 | EP1064253B1 Anti-tumour agents |
| 01/29/2003 | EP1033369B1 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 01/29/2003 | EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/29/2003 | EP1024815B1 Pharmaceutical compositions for oral administration of molecular iodine |
| 01/29/2003 | EP0858465B1 Anti-tumoral protein |
| 01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
| 01/29/2003 | CN1394206A Novel vitamin D analogues |
| 01/29/2003 | CN1394205A Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 01/29/2003 | CN1394201A Substituted glutarimides and use thereof IL-12 production inhibitors |
| 01/29/2003 | CN1394141A Fulvestrant formulation |
| 01/29/2003 | CN1394139A Anticancer agents |
| 01/29/2003 | CN1393559A Configuration and application of liver cancer specific genetically engineered adenovirus |
| 01/29/2003 | CN1393475A Micromolecular lung cancer antibody targeted immunotoxin and its equipment, preparing process and usage |
| 01/29/2003 | CN1393451A Platinum match and its preparing process and usage |
| 01/29/2003 | CN1393438A Taxane derivative and its preparing process and usage |
| 01/29/2003 | CN1393244A Chinese medicine for treating esophagus cancer and cardia cancer |
| 01/29/2003 | CN1393236A Medicine 'Aibixiao' for treating cancer |
| 01/29/2003 | CN1393234A 'Jingema' honeyed cream for antipyresis and detoxication |
| 01/29/2003 | CN1100063C Ginkgo testa polysaccharide and preparing process of pharmaceutical thereof |
| 01/29/2003 | CN1100058C Novel intermediates and process for manufacture of camptothecin derivatives (CPT-11) and related compounds |
| 01/29/2003 | CN1100046C 喹唑啉衍生物 Quinazoline derivatives |
| 01/29/2003 | CN1100036C Prourokinase and urokinase affinity ligand and its usage |
| 01/29/2003 | CN1099894C Vaccine composition for eliciting immune response against N-glycolylated gangliosides and its use |
| 01/29/2003 | CN1099892C Process for separating antineoplastic component from glossy ganoderma spore |
| 01/29/2003 | CN1099891C Composite glossy ganoderma spore powder |
| 01/29/2003 | CN1099890C Guangyehehuan anticancer medicine and its prepn. method |
| 01/29/2003 | CN1099886C Medicine for nasopharyngeal cancer and its preparing process |
| 01/29/2003 | CN1099869C Photosensibilizers |
| 01/29/2003 | CA2417579A1 Method of proliferating natural killer cells |
| 01/28/2003 | WO2002018372A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 01/28/2003 | US6512123 Antiproliferative agents |
| 01/28/2003 | US6512104 Interleukin-1β converting enzyme like cysteine protease |
| 01/28/2003 | US6512102 Compositions and methods of diagnosis and treatment using casein kinase I |
| 01/28/2003 | US6512101 Branched hydrazone linkers |
| 01/28/2003 | US6512096 Prostate cell surface antigen-specific antibodies |
| 01/28/2003 | US6512007 Treatment of inflammatory processes induced by excessive expression of the IL-6-induced acute phase proteins |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | US6511988 Prevention binding of transcription factor tozinc finger binding compounds |
| 01/28/2003 | US6511986 Method of treating estrogen receptor positive carcinoma |
| 01/28/2003 | US6511978 Pyrrole derivatives useful for farnesyl transferase inhibitors and their preparations |
| 01/28/2003 | US6511971 Substituted perhalogenated phthalocyanines |
| 01/28/2003 | US6511847 Recombinant adenovirus using liposome-mediated cotransfection and the direct observation of a cytopathic effect in the transfected cells; tumor suppressor gene |
| 01/28/2003 | US6511825 Cell signaling polypeptides and nucleic acids |
| 01/28/2003 | US6511676 Forming cisplatin and ethanol buffered solution; combining with a negatively charged phosphatidyl glycerol lipid deriva-tive; able to reach primary tumors and their metastases after intravenous injection; breast and prostate cancer |
| 01/28/2003 | US6511670 (poly)thiaalkynoic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/28/2003 | US6511661 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 01/28/2003 | US6511648 Vitronectin receptor antagonist pharmaceuticals |
| 01/28/2003 | CA2318432C The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/28/2003 | CA2127553C Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 01/28/2003 | CA2123124C Photosensitizers |